Literature DB >> 22772450

miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.

Kristen M Smith1, Mireia Guerau-de-Arellano, Stefan Costinean, Jessica L Williams, Arianna Bottoni, Gina Mavrikis Cox, Abhay R Satoskar, Carlo M Croce, Michael K Racke, Amy E Lovett-Racke, Caroline C Whitacre.   

Abstract

Th cell programming and function is tightly regulated by complex biological networks to prevent excessive inflammatory responses and autoimmune disease. The importance of microRNAs (miRNAs) in this process is highlighted by the preferential Th1 polarization of Dicer-deficient T cells that lack miRNAs. Using genetic knockouts, we demonstrate that loss of endogenous miR-29, derived from the miR-29ab1 genomic cluster, results in unrestrained T-bet expression and IFN-γ production. miR-29b regulates T-bet and IFN-γ via a direct interaction with the 3' untranslated regions, and IFN-γ itself enhances miR-29b expression, establishing a novel regulatory feedback loop. miR-29b is increased in memory CD4(+) T cells from multiple sclerosis (MS) patients, which may reflect chronic Th1 inflammation. However, miR-29b levels decrease significantly upon T cell activation in MS patients, suggesting that this feedback loop is dysregulated in MS patients and may contribute to chronic inflammation. miR-29 thus serves as a novel regulator of Th1 differentiation, adding to the understanding of T cell-intrinsic regulatory mechanisms that maintain a balance between protective immunity and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772450      PMCID: PMC3411895          DOI: 10.4049/jimmunol.1103171

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12.

Authors:  Edda G Schulz; Luca Mariani; Andreas Radbruch; Thomas Höfer
Journal:  Immunity       Date:  2009-04-30       Impact factor: 31.745

2.  Widespread changes in protein synthesis induced by microRNAs.

Authors:  Matthias Selbach; Björn Schwanhäusser; Nadine Thierfelder; Zhuo Fang; Raya Khanin; Nikolaus Rajewsky
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

3.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

4.  miRNAs in multiple sclerosis: regulating the regulators.

Authors:  Mireia Guerau-de-Arellano; Amy E Lovett-Racke; Michael K Racke
Journal:  J Neuroimmunol       Date:  2010-12-15       Impact factor: 3.478

5.  MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

Authors:  Andreas Junker; Markus Krumbholz; Sylvia Eisele; Hema Mohan; Florian Augstein; Robert Bittner; Hans Lassmann; Hartmut Wekerle; Reinhard Hohlfeld; Edgar Meinl
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

6.  Expression of Th1 and Th17 cytokines and transcription factors in multiple sclerosis patients: does baseline T-bet mRNA predict the response to interferon-beta treatment?

Authors:  Jelena Drulovic; Emina Savic; Tatjana Pekmezovic; Sarlota Mesaros; Nebojsa Stojsavljevic; Irena Dujmovic-Basuroski; Jelena Kostic; Vladimir Vasic; Marija Mostarica Stojkovic; Dusan Popadic
Journal:  J Neuroimmunol       Date:  2009-08-19       Impact factor: 3.478

7.  Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.

Authors:  Christine Mayr; David P Bartel
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

Review 8.  Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Authors:  Ethan M Shevach
Journal:  Immunity       Date:  2009-05       Impact factor: 31.745

9.  Dicer-dependent microRNA pathway safeguards regulatory T cell function.

Authors:  Adrian Liston; Li-Fan Lu; Donal O'Carroll; Alexander Tarakhovsky; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

10.  The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease.

Authors:  Mark M W Chong; Jeffrey P Rasmussen; Alexander Y Rudensky; Alexander Y Rundensky; Dan R Littman
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more
  76 in total

1.  A Novel miR-24-TCF1 Axis in Modulating Effector T Cell Responses.

Authors:  Sunglim Cho; Cheng-Jang Wu; Duc T Nguyen; Ling-Li Lin; Mei-Chi Chen; Aly Azeem Khan; Bi-Huei Yang; Wenxian Fu; Li-Fan Lu
Journal:  J Immunol       Date:  2017-04-12       Impact factor: 5.422

2.  Increased micro-RNA 29b in the aged brain correlates with the reduction of insulin-like growth factor-1 and fractalkine ligand.

Authors:  Ashley M Fenn; Kristen M Smith; Amy E Lovett-Racke; Mireia Guerau-de-Arellano; Caroline C Whitacre; Jonathan P Godbout
Journal:  Neurobiol Aging       Date:  2013-07-21       Impact factor: 4.673

Review 3.  MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development.

Authors:  Katie Podshivalova; Daniel R Salomon
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.

Authors:  Parvathi Ranganathan; Apollinaire Ngankeu; Nina C Zitzer; PierPaolo Leoncini; Xueyan Yu; Lucia Casadei; Kishore Challagundla; Dawn K Reichenbach; Sabrina Garman; Amy S Ruppert; Stefano Volinia; Jessica Hofstetter; Yvonne A Efebera; Steven M Devine; Bruce R Blazar; Muller Fabbri; Ramiro Garzon
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

5.  Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.

Authors:  Rebecca Kohnken; Jing Wen; Bethany Mundy-Bosse; Kathleen McConnell; Ashleigh Keiter; Leah Grinshpun; Alex Hartlage; Max Yano; Betina McNeil; Nitin Chakravarti; Basem William; James E Bradner; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

Review 6.  The inflammatory effect of epigenetic factors and modifications in type 2 diabetes.

Authors:  Mohamad Akbari; Vahideh Hassan-Zadeh
Journal:  Inflammopharmacology       Date:  2019-11-09       Impact factor: 4.473

Review 7.  Re-evaluating Strategies to Define the Immunoregulatory Roles of miRNAs.

Authors:  Adriana Forero; Lomon So; Ram Savan
Journal:  Trends Immunol       Date:  2017-06-27       Impact factor: 16.687

Review 8.  Immuno-miRs: critical regulators of T-cell development, function and ageing.

Authors:  Bart-Jan Kroesen; Nato Teteloshvili; Katarzyna Smigielska-Czepiel; Elisabeth Brouwer; Anne Mieke H Boots; Anke van den Berg; Joost Kluiver
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

Review 9.  The biological functions of miRNAs: lessons from in vivo studies.

Authors:  Joana A Vidigal; Andrea Ventura
Journal:  Trends Cell Biol       Date:  2014-12-04       Impact factor: 20.808

10.  MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.

Authors:  Mary E Severin; Priscilla W Lee; Yue Liu; Amanda J Selhorst; Matthew G Gormley; Wei Pei; Yuhong Yang; Mireia Guerau-de-Arellano; Michael K Racke; Amy E Lovett-Racke
Journal:  Brain       Date:  2016-04-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.